Comorbidities in older patients with HIV A retrospective study

Journal of the American Dental Association

Volumn 138, Issue 11, 2007, Pages 1468-1475

  Magalhães, Marina Gallottini ^a   Greenberg, Barbara ^b   Hansen, Heidi ^b   Odont, Cand ^e   Glick, Michael ^c,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^c A T STILL UNIVERSITY   (United States)

^d A T STILL UNIVERSITY   (United States)

^e AT Still University ^*

Author keywords

Aging; Anemia; Cardiovascular diseases; Hepatitis; HIV infection; Hypertension; Virus

Indexed keywords

EID: 37149045835     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2007.0083     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. National Prevention Information Network. Communities at risk: The elderly. Available at: "www.cdcnpin.org/scripts/population/elderly.asp". Accessed Feb. 28, 2007.
2. Shah S, Mildvan D. HIV and aging. Curr Infect Dis Rep 2006;8(3): 241-7.
3. Manfredi R. HIV infection and advanced age emerging epidemiological, clinical, and management issues. Ageing Res Rev 2004;3(1): 31-54.
4. Palácios R, Santos J, Garcia A, et al. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients: a prospective study in a cohort of naive patients. HIV Medicine 2006; 7(1):10-5.
5. Goodroad BK. HIV and AIDS in people older than 50: a continuing concern. J Gerontol Nurs 2003;29(4):18-24.
6. Grabar S, Kousignian I, Sobel A, et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age: results from the French Hospital Database on HIV. AIDS 2004; 18 (151:2029-38.
7. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006,144 (10):705-14.
8. Lacombe K, Pacanowski J. HIV infection and comorbidities (in French). Rev Prat 2006;56(9):995-1004.
9. Greenberg MS, Glick M, eds. Burket's oral medicine: Diagnosis and treatment. Hamilton, Ontario, Canada: Decker; 2003.
10. Dighe AS, Rao A, Coakley AB, Lewandrowski KB. Analysis of laboratory critical value reporting at a large academic medical center. Am Clin Pathol 2006;125(5):758-64.
11. Lewden C, Salmon D, Morlat P, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005;34(1):121-30.
12. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006;166(15):1632-41.
13. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006;44(1 supplement):S6-S9.
14. Hagan H, Campbell J, Thiede H, et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep 2006;121(6):710-9.
15. Demas P, McClain JR. Hepatitis: implications for dental care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod1999;88(1):2-4.
16. National Center for Health Statistics, National Center for Health Services Research. Health, United States, 2006: With chartbook on trends in the health of Americans. Rockville, Md.: U.S. Department of Health, Education, and Welfare, Public Health Service, Health Resources Administration, National Center for Health Statistics; 2006:279.
17. Glick M. Medical considerations for dental practice. Chicago: Quintessence; 2005.
18. Olatunji BO, Mimiaga MJ, O'Cleirigh C, Safren SA. Review of treatment studies of depression in HIV. Top HIV Med 2006;14(3): 112-24.
19. Odiase F, Ogunrin O, Ogunniyi A. Effect of progression of disease on cognitive performance in HIV/AIDS. J Natl Med Assoc 2006;98(8): 1260-2.
20. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002;8(2):136-42.
21. Bell JE. An update on the neuropathology of HIV in the HAART era. Histopathology 2004;45(6):549-59.
22. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003;290(17):2301,12.
23. Crothers K, Butt AA, Gibert CL, Rodriquez-Barradas MC, Crystal S, Justice AC; Veterans Aging Cohort 5 Project Team. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006; 130(5)1326-33.
24. Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005;20(12):1142-5.
25. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immmunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998;91(1):301-8.
26. Berhane K, Karim R, Cohen MH, et al. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women. J Acquir Immune Defic Syndr 2004;37(2):1245-52.
27. Semba RD, Shah N, Klein RS, Mayer KH, Schuman P, Vlahov D; Human Immunodeficiency Virus Epidemiology Research Study Group. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and-uninfected women. Clin Infect Dis 2002;34(2):260-6.
28. Zon LI Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol 1988;25(3):208-18.
29. Moses A, Nelson J, Bagby GC Jr. The influence of human immunodeficiency virus-1 on hematopoieses. Blood 1998;91(5):1479-85.
30. Levine AM, Karim R, Mack W, et al. Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study. Arch Intern Med 2006;166(4):405-10.
31. Patton LL. Hematological abnormalities among HIV-infected patients: associations of significance for dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88(5):561-7.